James Dahlman is an Assistant Professor in the Georgia Tech Department of Biomedical Engineering. The Dahlman Lab for Precision Therapies works at the interface of drug delivery, nanotechnology, genomics, and gene editing. James has designed nanoparticles that deliver RNA to blood vessels in the heart and lung; these nanoparticles have been validated by labs across the US. James also uses molecular biology to rationally design the genetic drugs he delivers. He designed ‘dead’ guide RNAs to turn on genes using active Cas9. Similarly, using his background in nanoparticle chemistry, in vivo RNA delivery, and genomics, his lab designed a nanoparticle DNA barcoding system to measure how >200 nanoparticles target cells at once, directly in vivo. James’ barcoding work led to his placement on the Tech Review TR35 list. In addition to the TR35, James has the NSF, NDSEG, NIH OxCam, Whitaker, and LSRF Fellowships, the Weintraub Graduate Thesis Award, and has been named a young / leading investigator by Bayer, the Parkinson’s Disease Foundation, and the Journal of Materials Chemistry B. His research has been published in Nature Nano, Nature Biotech, Nature Cell Bio, Science Trans Med, Cell, PNAS (2x), Nano Letters (2x), ACS Nano, JACS, and other leading journals. He has given >60 invited presentations on drug delivery, gene editing, and DNA barcoding across the world.

Education Education Professionals, College, Technology, Medicine,